Current Cancer Drug Targets, Volume 17 - Number 1

Meet Our Editorial Board Member

, 17(1): 1

G. S.W. Tsao

DOI: 10.2174/156800961701161202195944


Preface: Scientific Premise and Rigors in Scientific Research, Peer Review, Editing and Publishing

, 17(1): 2

Ruiwen Zhang

DOI: 10.2174/156800961701161202200123

Review Article

LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers

, 17(1): 3 - 16

Uzma Malik and Aneela Javed

DOI: 10.2174/156800961701161202200445

Review Article

Novel Strategies to Discover Effective Drug Targets in Metabolic and Immune Therapy for Glioblastoma

, 17(1): 17 - 39

Gang Wang, Xing-Li Fu, Jun-Jie Wang, Rui Guan and Xiang-Jun Tang

DOI: 10.2174/1568009616666160512145436

Review Article

OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy

, 17(1): 40 - 47

Nana Zheng, Ping Yang, Zhiwei Wang and Quansheng Zhou

DOI: 10.2174/1568009616666160216130608

Review Article

Novel Synthetic Lethality Approaches for Drug Combinations and Early Drug Development

, 17(1): 48 - 52

Alberto Ocana and Atanasio Pandiella

DOI: 10.2174/1568009616666151203224714

Review Article

UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target

, 17(1): 53 - 61

Samantha Banford and David J. Timson

DOI: 10.2174/1568009616666160922102641

Research Article

Does Hypoxic Response Mediate Primary Resistance to Sunitinib in Untreated Locally Advanced Breast Cancer?

, 17(1): 62 - 73

Sofia Braga, Joana Cardoso, Saudade Andre, Margarida Brito, Pedro Sanchez, Lurdes Orvalho, Lucilia Salgado, Sergio Dias, Jose B. Pereira-Leal and Jose Luis Passos-Coelho

DOI: 10.2174/1568009616666161025114914

Research Article

Strong Anti-tumorous Potential of Nardostachys jatamansi Rhizome Extract on Glioblastoma and In Silico Analysis of its Molecular Drug Targets

, 17(1): 74 - 88

Himanshi Kapoor, Nalini Yadav, Madhu Chopra, Sushil Chandra Mahapatra and Veena Agrawal

DOI: 10.2174/1570163813666161019143740

Research Article

EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In Vivo

, 17(1): 89 - 97

Chenfei Zhou, Liangjun Zhu, Jun Ji, Fangmi Ding, Chao Wang, Qu Cai, Yingyan Yu, Zhenggang Zhu and Jun Zhang

DOI: 10.2174/1568009616666161013101657

Webmaster Contact:
Copyright © 2018 Bentham Science